Megan Miyahira
Women's Health · Torrance, CANPI 1467883215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,005 and has fallen 65.7% since, to $344 in 2025. Among women's health clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$447
- Mayne Pharma Commercial LLC$402
- Novo Nordisk$197
- Bayer$154
- AbbVie$139
- Astellas Pharma US Inc$136
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,50399%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 20 | $447 |
| Mayne Pharma Commercial LLC | 43 | $402 |
| Novo Nordisk | 6 | $197 |
| Bayer | 7 | $154 |
| AbbVie | 7 | $139 |
| Astellas Pharma US Inc | 6 | $136 |
| Myovant Sciences Inc. | 7 | $123 |
| Evofem Biosciences, Inc. | 7 | $121 |
| Exeltis, USA Inc. | 4 | $86 |
| Agile Therapeutics, Inc. | 5 | $84 |
| Aspira Women's Health Inc | 4 | $82 |
| Pfizer | 4 | $78 |
| Exact Sciences | 4 | $77 |
| Hologic Sales And Service, LLC | 3 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Currax Pharmaceuticals LLC | 3 | $48 |
| Boston Scientific | 2 | $46 |
| Millicent US Inc | 2 | $44 |
| Ascend Therapeutics US, LLC | 2 | $35 |
| Cepheid | 1 | $34 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$110
How this compares
$2,519 in reported general payments places this provider in the 90th percentile of 480 women's health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 21 | $1,145 |
| Estradiol | 11 | $523 |
Paid to pharmacies, not to this prescriber.
Other women's health in Torrance
- Donna EspinosaTorrance$3K
- Barbara DehnMountain View$87K
- Zaruhi HarutyunyanWest Hollywood$55K
- Roberta MoradfarWest Hollywood$30K
- Patricia GeraghtyWalnut Creek$26K
- Katherine KetzStockton$26K
- Debbie BarishBerkeley$16K
- Raisa HowardEl Segundo$11K
- Mary FesselWoodland$8K
- Kay MorelandSanta Maria$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.